Daan Gene Co., Ltd. (SHE:002030)
China flag China · Delayed Price · Currency is CNY
5.28
-0.13 (-2.40%)
Sep 11, 2026, 3:04 PM CST

Daan Gene Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Net Income
-678.72-744.38-925.17104.665,4123,618
Depreciation & Amortization
235.07295.33350.36357.14298.44192.02
Other Amortization
43.124.5311.3710.8234.7820.45
Loss (Gain) From Sale of Assets
-5-5.48-9.13.041.15-0.11
Asset Writedown & Restructuring Costs
567.55385.8431.2880.89329.7915
Loss (Gain) From Sale of Investments
-70.25-54429.58-409.44-345.15-135.35
Provision & Write-off of Bad Debts
105.04105.04397.98142.36297.82130.73
Other Operating Activities
-191.7128.4342.35169.99333.628.07
Change in Accounts Receivable
349.23398.87745.691,768-2,659-953.23
Change in Inventory
33.9441.2780.69-61.27-112.02-187.42
Change in Accounts Payable
-76.56-178.57-715.42-1,389649.84645.12
Operating Cash Flow
355.82319.49300.33780.114,1553,305
Operating Cash Flow Growth
31.91%6.38%-61.50%-81.22%25.73%31.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Capital Expenditures
-140.02-239-174.41-572.77-1,503-658.75
Sale of Property, Plant & Equipment
0.180.420.110.450.010.15
Cash Acquisitions
------0.04
Divestitures
--0--0.02
Investment in Securities
-58.27-428.42-71.95442.98-505.95-746.99
Other Investing Activities
-3629.6828.8665.6548.7726.33
Investing Cash Flow
-234.11-637.32-217.39-63.69-1,960-1,379

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Short-Term Debt Issued
-123.01147.85318.52124.6284.55
Long-Term Debt Issued
-4.946.83550.0345
Total Debt Issued
139.53127.91194.65353.52174.64329.55
Short-Term Debt Repaid
--158.05-357.67-125.46-284.34-398.75
Long-Term Debt Repaid
--5.96-15.06-82.7-104.33-52.08
Total Debt Repaid
-120.44-164.01-372.73-208.16-388.67-450.83
Net Debt Issued (Repaid)
19.08-36.1-178.08145.36-214.03-121.28
Common Dividends Paid
-8.79-8.46-27.88-2,469-1,570-496.31
Other Financing Activities
-10.69----10.96-8.96
Financing Cash Flow
-0.39-44.55-205.96-2,323-1,795-626.55

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-2.31-1.331.112.2627.53-3.24
Net Cash Flow
119-363.71-121.9-1,605427.931,295

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Free Cash Flow
215.880.49125.92207.342,6522,646
Free Cash Flow Growth
278.88%-36.08%-39.27%-92.18%0.24%23.08%
Free Cash Flow Margin
28.89%10.62%14.76%17.56%22.02%34.52%
Free Cash Flow Per Share
0.160.060.090.141.891.89
Levered Free Cash Flow
-129.51425.76432.931,4571,665
Unlevered Free Cash Flow
-132.13431.85439.211,4661,671

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Jan '23 Jan '22
Cash Income Tax Paid
20.8229.1650.76253.761,504754.19
Change in Working Capital
344.81278.24-37.15320.01-2,206-555.75